China SXT Pharmaceuticals (SXTC) Non-Current Assets (2018 - 2026)
China SXT Pharmaceuticals (SXTC) recorded Non-Current Assets of $244,852 in fiscal Q4 2026 (quarter ended Mar 31, 2026), down 33.3% from $367,017 a year earlier.
Powered by 
Analysis
China SXT Pharmaceuticals (SXTC) Non-Current Assets (2018 - 2026) Analysis & Trends
Starting with fiscal Q4 2018, China SXT Pharmaceuticals' Non-Current Assets history includes 17 quarters.
- Annual Non-Current Assets has declined for five straight fiscal years, with a five-year compound annual growth rate of -53.5% (FY2021 to FY2026).
- Across earlier fiscal years, Non-Current Assets came in at $367,017 in FY2025 (-95.9%), $8.89 million in FY2024 (-11.4%), $10.03 million in FY2023 (-9.6%) and $11.09 million in FY2022 (-1.9%).
- The fiscal Q4 2026 figure is the lowest quarterly Non-Current Assets in data going back to fiscal Q4 2018.
- On a year-over-year basis, Non-Current Assets rose in 1 of the last four quarters, with growth averaging 124.7%.
- Peak year-over-year performance for Non-Current Assets in the last five years was growth of 724.5% in fiscal Q2 2025, against a decline of 96.5% in fiscal Q2 2026 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | China SXT Pharmaceuticals | 33,069.96 | -85.92 Mn | - | 244,852.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 244,852.00 |
| Sep 30, 2025 | 310,889.00 |
| Mar 31, 2025 | 367,017.00 |
| Sep 30, 2024 | 9.01 Mn |
| Mar 31, 2024 | 8.89 Mn |
| Sep 30, 2023 | 1.09 Mn |
| Mar 31, 2023 | 10.03 Mn |
| Sep 30, 2022 | 9.82 Mn |
| Mar 31, 2022 | 11.09 Mn |
| Sep 30, 2021 | 11.01 Mn |
| Mar 31, 2021 | 11.31 Mn |
| Sep 30, 2020 | 1.98 Mn |
| Mar 31, 2020 | 2.07 Mn |
| Sep 30, 2019 | 5.50 Mn |
| Mar 31, 2019 | 1.88 Mn |
| Sep 30, 2018 | 1.45 Mn |
| Mar 31, 2018 | 1.56 Mn |
API Access
China SXT Pharmaceuticals Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=SXTC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "SXTC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=SXTC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();